Topic picture, symbol photo: Corona vaccine. Pfizer and BioNTech Announce Successful First Interim Analysis of their COVID-19 Vaccine Candidate in Current Phase 3 Trial A hand wrapped in rubber gloves holds a disposable syringe of vaccine for injection in a needle BIONTECH biotechnology company. | usage worldwide
The World Health Organization (WHO) accepted Thursday the COVID-19 vaccine collectively developed by Pfizer and BioNTech for emergency use, racing the process of regulatory approval and acquisition for all nations worldwide.
“This is a very positive step towards ensuring global access to COVID-19 vaccines. But I want to emphasize the need for an even greater global effort to achieve enough vaccine supply to meet the needs of priority populations everywhere,” WHO’s executive dr Mariangela Simao stated about the approval. Nevertheless, the WHO’s expert group is yet to gather on January 5 to settle on policies and recommendations which should be followed during the jab’s use in wider populations.
The move enables UNICEF and the Pan-American Health Organization to support the vaccine’s distribution to countries in need
Commodities are one of the cornerstones of the global economy, vital for powering construction projects,…
The International Court of Justice in The Hague said Friday it would issue a verdict…
Heavy rainfalls that hit Kenya during the last few days left at least 75 people…
International Olympic Committee (IOC) President Thomas Bach confirmed that the IOC is committed to inviting…
According to a bulletin from the National Institute of Meteorology (INM), the month of March…
Thousands of supporters of the Spanish Socialist Party assembled in Madrid, near the party headquarters,…
This website uses cookies.